How does the World Health Organization help countries develop drug standards?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

The World Health Organization (WHO) assists countries in developing drug standards through several key initiatives aimed at ensuring global consistency, safety, and quality in medicine:

  • International Pharmacopoeia: Since the early 1950s, the WHO has published the International Pharmacopoeia. This resource provides standardized nomenclature, strengths, and quality specifications for drugs, serving as a vital reference for countries that do not have their own national pharmacopoeia.12
  • Expert Panels: The WHO convenes international panels of experts in fields such as medicine, law, and pharmaceutical development. These panels are responsible for recommending standards that countries can adopt for their own national drug laws and regulatory frameworks.3
  • Harmonization: By providing these recommendations and standards, the WHO works to minimize or eliminate variations among national pharmacopoeial standards, helping to ensure that therapeutic drugs meet consistent requirements for purity and strength worldwide.12

These efforts are fundamental to the global pharmaceutical industry, as they support the common good by promoting the availability of safe and effective medicines across different nations.3